Sauad Indústria Farmacêutica is a subsidiary of UAE based, global pharmaceutical manufacturer, Neopharma. A dynamic global organization, dedicated to fulfil patients' needs by providing quality medicines and innovative medications at affordable cost.
Sauad Farmacêutica was founded in 1968 by Auad Family as AUAD QUÍMICA in Goiânia-GO. It began its activities with the objective of producing medicines to treat skin diseases particularly vitiligo. On August 21, 2007, AUAD Química was acquired by a Brazilian business group and renamed as Sauad Farmacêutica. Subsequently, Sauad Farmacêutica was acquired by Neopharma LLC on 4th May 2018 and is now part of Neopharma International Holdings. With an Integrated Health Care approach, Sauad Farmacêutica is dedicated to deliver breakthrough solutions to the market, solve complex challenges, and most importantly, meet partners and patients' expectations through high quality, innovative and accessible solutions.
Neopharma, an Abu Dhabi based, global pharmaceutical company is one of the largest pharmaceutical manufacturers in the in MENA region. A vertically integrated business model, economies of scale and an extremely skilled team enable us to deliver quality products in a timely manner at affordable prices in over 50 countries worldwide.
Neopharma's global presence is supported by 5 manufacturing facilities spread across 3 continents delivering a wide range of branded and generic formulations, and active pharmaceutical ingredients (APIs). The therapeutic segments covered by our portfolio of over 100 high-quality molecules include anti-infective, neurology, cardiology, orthopedics, diabetology, gastroenterology, urology, dermatology, gynecology, respiratory, dental and nutritional products.
To know more on our global manufacturing and marketing networks click here.